USA – DePuy Synthes, a Johnson & Johnson orthopedics company, has paid an undisclosed sum for the acquisition of CrossRoads Extremity Systems, a US-based foot and ankle company.

CrossRoads, headquartered in Tennessee, USA, provides a variety of procedure-specific, sterile-packed implants and instrumentation systems for lower extremity indications.

CrossRoads’ majority investor, private equity firm Healthpoint Capital, had worked with the company to help it grow into a growth leader in the foot and ankle segment.

DePuy Synthes’ commitment to drive orthopedic, podiatric, and medtech advancements through both internal and external innovation is reflected in this acquisition.

CrossRoads’ more than two dozen devices are focused on tools for foot and ankle surgeries, with its flagship products consisting of implant systems to treat all severity levels of bunion deformities.

CrossRoads’ product portfolio comprises of miniBunion3D, dynaBunion 4D, and DynaForce staple compression plates.

The miniBunion system is a minimally invasive approach to metatarsal bone osteotomy, a procedure used to treat mild to moderate hallux valgus. The system aids in reducing the size of the incision as compared to traditional techniques.

The miniBunion system, for example, is intended to be a less invasive alternative to other traditional metatarsal bone osteotomy techniques, whereas the dynaBunion 4D system functions as an extra pair of hands for surgeons during Lapidus bunionectomies, which is a procedure used to treat moderate to severe hallux valgus.

At the fusion site, DynaForce staple compression plates combine stability with dynamic continuous compression.

All of the systems are surgical options for treating a variety of bunion deformities ranging from mild to severe.

It provides instrumentation and implants for the four-dimensional correction of bunions through smaller incisions.

The acquisition will assist Depuy Synthes in meeting a growing demand for elective surgeries to treat foot conditions such as hammertoes and bunions.

The CrossRoads acquisition comes just about a month after DePuy’s previous acquisition. The J&J devicemaker, acting through its Synthes GmbH affiliate, purchased OrthoSpin in that deal, which was announced in early December.

The Israeli-based company has created an automated strut system that is already being used with DePuy’s Maxframe circular ring fixation system, which is used to stabilize a leg, foot, or arm following an orthopedic procedure.

J&J was the lead investor in OrthoSpin’s series A and B funding rounds in 2018 and 2020, respectively, prior to acquiring the company.

CrossRoads also offers the EcoSMART instrument service, which provides sterile and reusable surgical instruments, as well as post-surgery instrument recovery and processing to reduce waste and inefficiencies in the operating room.

According to DePuy, the acquisition will assist it in meeting a growing demand for elective surgeries to treat foot conditions such as hammertoes and bunions, the latter of which affects approximately one in every four people in the United States alone.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE